We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining exploration companies often lose money for years before finding success with a new ...

Initial patient treatment confirms system's accuracy and ease of use US launch of Hummingbird Solo system expands the Hummingbird ICP Monitoring product family, allowing IRRAS to more completely ...

STOCKHOLM, June 18, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial stage medical technology company with a comprehensive portfolio of innovative products for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

- Publication also documents the ability to deliver targeted thrombolytic medication via IRRAflow's recurring irrigation for the first time in peer-reviewed scientific literature STOCKHOLM, May 28, ...

Acquisition Will Further Expand the Potential of ClearPoint Neuro's Drug Delivery Portfolio While Immediately Adding New Indications and Commercial Scale Across a $0.5 Billion Market for the Treatment ...

Commercial partnership underway to wrap up meaningful year of growth STOCKHOLM, Feb. 16, 2023 /PRNewswire/ -- "Q4 2022 marked the conclusion of a transformational year for IRRAS, and, as we begin the ...

Stockholm, November 22, 2017 — Nasdaq (Nasdaq: NDAQ) announces that the trading in IRRAS AB’s shares (short name: IRRAS) commenced today on Nasdaq First North Premier in Stockholm. IRRAS belongs to ...

Irras Stock Price History Explore Irras stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to analyze past trends and ...

IRRAflow, a commercially available medical device system for the treatment of intracranial bleeding, is the world's first "irrigating ventricular drain," and its unique mechanism of action addresses ...

STOCKHOLM, Feb. 16, 2023 /PRNewswire/ -- "Q4 2022 marked the conclusion of a transformational year for IRRAS, and, as we begin the new year, we have created new opportunities that will accelerate our ...

STOCKHOLM, Aug. 11, 2020 /PRNewswire/ -- IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced the first ...